Skip to main content
Erschienen in: Supportive Care in Cancer 4/2007

01.04.2007 | Review Article

Review of patterns of practice and patients’ preferences in the treatment of bone metastases with palliative radiotherapy

verfasst von: Nicole M. E. Bradley, Janice Husted, Michael Sai Lai Sey, Amna F. Husain, Emily Sinclair, Kristin Harris, Edward Chow

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Since the 1980s, randomized clinical trials showed that single fraction radiotherapy (RT) provided equal pain relief as multiple fractions of RT in the treatment of bone metastases.

Materials and methods

Using Medline, a literature search was conducted on patterns of practice among radiation oncologists and patients’ preferences of dose fractionations for the treatment of bone metastases.

Results and discussion

Fifteen studies on international patterns of practice published between 1966 and May 2006 were identified. Surveys of Canadian radiation oncologists indicated approximately 85% preferred multiple fractions, most often as 20 Gray in five fractions (20 Gy/5). Surveys in the United States indicated that 30 Gy/10 was most commonly used, and 90–100% of these oncologists preferred multiple over single fraction RT. Multiple fractions were most commonly used in the United Kingdom, Western Europe, Australia and New Zealand, and India; however, more radiation oncologists in these countries would prescribe a single fraction than in North America. Three studies investigated patients’ preferences of dose fractionations. In the Australian study, most patients favored single fraction RT as long as long-term outcomes were not compromised. Durability of pain relief was considered more important than short-term convenience factors. In the Singapore study, 85% of patients would choose extended courses of RT (24 Gy/6) compared to a single 8 Gy. In the Canadian study, most patients (76%) would choose a single 8 Gy over 20 Gy/5 of palliative RT due to greater convenience.

Conclusion

Despite strong evidence supporting the use of single fraction RT, current practices and preferences favor multiple fractions for the treatment of bone metastases. This has significant implications for the overall quality of life, RT department workload, costs to healthcare systems, and patient convenience.
Literatur
1.
Zurück zum Zitat Amichetti M, Orrù P, Madeddu A et al (2004) Comparative evaluation of two hypofractionated radiotherapy regimens for painful bone metastases. Tumori 90(1):91–95PubMed Amichetti M, Orrù P, Madeddu A et al (2004) Comparative evaluation of two hypofractionated radiotherapy regimens for painful bone metastases. Tumori 90(1):91–95PubMed
2.
Zurück zum Zitat Barton MB, Dawson R, Jacob S et al (2001) Palliative radiotherapy of bone metastases: an evaluation of outcome measures. J Eval Clin Pract 7(1):47–64PubMedCrossRef Barton MB, Dawson R, Jacob S et al (2001) Palliative radiotherapy of bone metastases: an evaluation of outcome measures. J Eval Clin Pract 7(1):47–64PubMedCrossRef
3.
Zurück zum Zitat Belanger D, Moore M, Tannock I (1991) How American oncologists treat breast cancer: an assessment of the influence of clinical trials. J Clin Oncol 9(1):7–16PubMed Belanger D, Moore M, Tannock I (1991) How American oncologists treat breast cancer: an assessment of the influence of clinical trials. J Clin Oncol 9(1):7–16PubMed
4.
Zurück zum Zitat Ben-Josef E, Shamsa F, Williams AO, Porter AT (1998) Radiotherapeutic management of osseous metastases: a survey of current practices of care. Int J Radiat Oncol Biol Phys 40(4):915–921PubMedCrossRef Ben-Josef E, Shamsa F, Williams AO, Porter AT (1998) Radiotherapeutic management of osseous metastases: a survey of current practices of care. Int J Radiat Oncol Biol Phys 40(4):915–921PubMedCrossRef
5.
Zurück zum Zitat Bentzen SM, Hoskin P, Roos D, Nielsen OS (2000) Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or...? (Letter). Int J Radiat Oncol Biol Phys 46(3):681–683PubMedCrossRef Bentzen SM, Hoskin P, Roos D, Nielsen OS (2000) Fractionated radiotherapy for metastatic bone pain: evidence-based medicine or...? (Letter). Int J Radiat Oncol Biol Phys 46(3):681–683PubMedCrossRef
6.
Zurück zum Zitat Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55(7):1468–1472PubMedCrossRef Blitzer PH (1985) Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 55(7):1468–1472PubMedCrossRef
7.
Zurück zum Zitat Bone Pain Trial Working Party (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 52(2):111–121CrossRef Bone Pain Trial Working Party (1999) 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 52(2):111–121CrossRef
8.
Zurück zum Zitat Chow E, Danjoux C, Connolly R et al (2000) Bone metastases: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. IJROB 44(1):1–18;1999. (Letter). Int J Radiat Oncol Biol Phys 46(2):517–518 Chow E, Danjoux C, Connolly R et al (2000) Bone metastases: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. IJROB 44(1):1–18;1999. (Letter). Int J Radiat Oncol Biol Phys 46(2):517–518
9.
Zurück zum Zitat Chow E, Danjoux C, Wong R et al (2000) Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol 56(3):305–314PubMedCrossRef Chow E, Danjoux C, Wong R et al (2000) Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol 56(3):305–314PubMedCrossRef
10.
Zurück zum Zitat Chow E, Lutz S, Beyene J (2003) A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases? Int J Radiat Oncol Biol Phys 55(3):565–567PubMedCrossRef Chow E, Lutz S, Beyene J (2003) A single fraction for all, or an argument for fractionation tailored to fit the needs of each individual patient with bone metastases? Int J Radiat Oncol Biol Phys 55(3):565–567PubMedCrossRef
11.
Zurück zum Zitat Coia LR, Hanks GE, Martz K et al (1988) Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys 14(6):1261–1269PubMed Coia LR, Hanks GE, Martz K et al (1988) Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys 14(6):1261–1269PubMed
12.
Zurück zum Zitat Cole DJ (1989) A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol) 1(2):59–62 Cole DJ (1989) A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol) 1(2):59–62
13.
Zurück zum Zitat Crellin AM, Marks A, Maher EJ (1989) Why don’t British radiotherapists give single fractions of radiotherapy for bone metastases? Clin Oncol (R Coll Radiol) 1(2):63–66 Crellin AM, Marks A, Maher EJ (1989) Why don’t British radiotherapists give single fractions of radiotherapy for bone metastases? Clin Oncol (R Coll Radiol) 1(2):63–66
14.
Zurück zum Zitat Dawson R, Currow D, Stevens G, Morgan G, Barton M (1999) Radiotherapy for bone metastases: a critical appraisal of outcome measures. J Pain Symptom Manage 17(3):208–218PubMedCrossRef Dawson R, Currow D, Stevens G, Morgan G, Barton M (1999) Radiotherapy for bone metastases: a critical appraisal of outcome measures. J Pain Symptom Manage 17(3):208–218PubMedCrossRef
15.
Zurück zum Zitat Duncan G, Duncan W, Maher EJ (1993) Patterns of palliative radiotherapy in Canada. Clin Oncol (R Coll Radiol) 5(2):92–97 Duncan G, Duncan W, Maher EJ (1993) Patterns of palliative radiotherapy in Canada. Clin Oncol (R Coll Radiol) 5(2):92–97
16.
Zurück zum Zitat Gaze MN, Kelly CG, Kerr GR et al (1997) Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 45(2):109–116PubMedCrossRef Gaze MN, Kelly CG, Kerr GR et al (1997) Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 45(2):109–116PubMedCrossRef
17.
Zurück zum Zitat Gupta T, Sarin R (2004) Palliative radiation therapy for painful vertebral metastases: a practice survey. Cancer 101(12):2892–2896PubMedCrossRef Gupta T, Sarin R (2004) Palliative radiation therapy for painful vertebral metastases: a practice survey. Cancer 101(12):2892–2896PubMedCrossRef
18.
Zurück zum Zitat Hall ET (1976) Beyond culture. Doubleday Dell Publishing Group, New York Hall ET (1976) Beyond culture. Doubleday Dell Publishing Group, New York
19.
Zurück zum Zitat Hartsell WF, Shah AB, Graney M, Kun LE (1998) Palliation of bone metastases in the USA: a survey of patterns of practice [abstract]. Support Care Cancer 6(2):175 Hartsell WF, Shah AB, Graney M, Kun LE (1998) Palliation of bone metastases in the USA: a survey of patterns of practice [abstract]. Support Care Cancer 6(2):175
20.
Zurück zum Zitat Hartsell WF, Scott CB, Bruner DW et al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804PubMedCrossRef Hartsell WF, Scott CB, Bruner DW et al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97(11):798–804PubMedCrossRef
21.
Zurück zum Zitat Kaasa S, Brenne E, Fayers P et al (2002) Single fraction radiotherapy (Gy × 1) versus multiple fraction (3 Gy × 10) for treatment of painful bone metastases—a multi-centre randomised trial. Abstracts of the 18th UICC International Cancer Congress. 30 June–5 July 2002. Oslo, Norway [abstract]. Int J Cancer Suppl 13:136 Kaasa S, Brenne E, Fayers P et al (2002) Single fraction radiotherapy (Gy × 1) versus multiple fraction (3 Gy × 10) for treatment of painful bone metastases—a multi-centre randomised trial. Abstracts of the 18th UICC International Cancer Congress. 30 June–5 July 2002. Oslo, Norway [abstract]. Int J Cancer Suppl 13:136
22.
Zurück zum Zitat Kachnic L, Berk L (2005) Palliative single-fraction radiation therapy: how much more evidence is needed? J Natl Cancer Inst 97(11):786–788PubMed Kachnic L, Berk L (2005) Palliative single-fraction radiation therapy: how much more evidence is needed? J Natl Cancer Inst 97(11):786–788PubMed
23.
Zurück zum Zitat Kagei K, Suzuki K, Shirato H, Nambu T, Yoshikawa H, Irie G (1990) A randomized trial of single and multifraction radiation therapy for bone metastasis: a preliminary report. Gan No Rinsho 36(15):2553–2558PubMed Kagei K, Suzuki K, Shirato H, Nambu T, Yoshikawa H, Irie G (1990) A randomized trial of single and multifraction radiation therapy for bone metastasis: a preliminary report. Gan No Rinsho 36(15):2553–2558PubMed
24.
Zurück zum Zitat Kirkbride P, Warde P, Panzarella A, Aslanidis J (2000) A randomised trial comparing the efficacy of a single fraction with fractionated radiation therapy in the palliation of skeletal metastases [abstract]. Int J Radiat Oncol Biol Phys 48(3):185CrossRef Kirkbride P, Warde P, Panzarella A, Aslanidis J (2000) A randomised trial comparing the efficacy of a single fraction with fractionated radiation therapy in the palliation of skeletal metastases [abstract]. Int J Radiat Oncol Biol Phys 48(3):185CrossRef
25.
Zurück zum Zitat Lawton PA, Maher EJ (1991) Treatment strategies for advanced and metastatic cancer in Europe. Radiother Oncol 22(1):1–6PubMedCrossRef Lawton PA, Maher EJ (1991) Treatment strategies for advanced and metastatic cancer in Europe. Radiother Oncol 22(1):1–6PubMedCrossRef
26.
Zurück zum Zitat Lievens Y, Kesteloot K, Rijnders A, Kutcher G, Van den Bogaert W (2000) Differences in palliative radiotherapy for bone metastases within Western European countries. Radiother Oncol 56(3):297–303PubMedCrossRef Lievens Y, Kesteloot K, Rijnders A, Kutcher G, Van den Bogaert W (2000) Differences in palliative radiotherapy for bone metastases within Western European countries. Radiother Oncol 56(3):297–303PubMedCrossRef
27.
Zurück zum Zitat Lievens Y, Van den Bogaert W, Rijnders A, Kutcher G, Kesteloot K (2000) Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol 56(3):289–295PubMedCrossRef Lievens Y, Van den Bogaert W, Rijnders A, Kutcher G, Kesteloot K (2000) Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol 56(3):289–295PubMedCrossRef
28.
Zurück zum Zitat Madsen EL (1983) Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy × 6 versus 10 Gy × 2. Int J Radiat Oncol Biol Phys 9(12):1775–1779PubMed Madsen EL (1983) Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy × 6 versus 10 Gy × 2. Int J Radiat Oncol Biol Phys 9(12):1775–1779PubMed
29.
Zurück zum Zitat Maher EJ, Coia L, Duncan G, Lawton PA (1992) Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys 23(1):239–244PubMed Maher EJ, Coia L, Duncan G, Lawton PA (1992) Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys 23(1):239–244PubMed
30.
Zurück zum Zitat Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1–2):1–18PubMedCrossRef Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69(1–2):1–18PubMedCrossRef
31.
Zurück zum Zitat Mikeljevic JS, Haward R, Johnston C et al (2004) Trends in postoperative radiotherapy delay and the effect on survival in breast caner patients treated with conservation surgery. Br J Cancer 90(7):1343–1348PubMedCrossRef Mikeljevic JS, Haward R, Johnston C et al (2004) Trends in postoperative radiotherapy delay and the effect on survival in breast caner patients treated with conservation surgery. Br J Cancer 90(7):1343–1348PubMedCrossRef
32.
Zurück zum Zitat Möller TR, Brorsson B, Ceberg J et al (2003) A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 42(5–6):387–410PubMedCrossRef Möller TR, Brorsson B, Ceberg J et al (2003) A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 42(5–6):387–410PubMedCrossRef
33.
Zurück zum Zitat Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR (1998) Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47(3):233–240PubMedCrossRef Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR (1998) Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 47(3):233–240PubMedCrossRef
34.
Zurück zum Zitat Nielsen O (2002) Should single fraction be recommended as radiotherapy for all uncomplicated bone metastases? Int J Cancer (Suppl. 13):7 Nielsen O (2002) Should single fraction be recommended as radiotherapy for all uncomplicated bone metastases? Int J Cancer (Suppl. 13):7
35.
Zurück zum Zitat Pant MC, Singh B, Srivastava M, Rai G (2002) Palliation of painful bone metastasis: the effect of 8 Gy in single fraction compared to multi-fractionated radiotherapy [abstract]. Int J Cancer 100(Suppl 13):513 Pant MC, Singh B, Srivastava M, Rai G (2002) Palliation of painful bone metastasis: the effect of 8 Gy in single fraction compared to multi-fractionated radiotherapy [abstract]. Int J Cancer 100(Suppl 13):513
36.
Zurück zum Zitat Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR (1986) Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6(4):247–255PubMed Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR (1986) Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 6(4):247–255PubMed
37.
Zurück zum Zitat Priestman TJ, Bullimore JA, Godden TP, Deutsch GP (1989) The Royal College of Radiologists’ Fractionation Survey. Clin Oncol (R Coll Radiol) 1(1):39–46 Priestman TJ, Bullimore JA, Godden TP, Deutsch GP (1989) The Royal College of Radiologists’ Fractionation Survey. Clin Oncol (R Coll Radiol) 1(1):39–46
38.
Zurück zum Zitat Ratanatharathorn V, Powers WE, Moss WT, Perez CA (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 44(1):1–18PubMedCrossRef Ratanatharathorn V, Powers WE, Moss WT, Perez CA (1999) Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 44(1):1–18PubMedCrossRef
39.
Zurück zum Zitat Ratanatharathorn V, Powers WE, Moss WT, Perez CA (2000) In response to Dr. Bentzen et al. (Letter). Int J Radiat Oncol Biol Phys 46(3):681–685CrossRef Ratanatharathorn V, Powers WE, Moss WT, Perez CA (2000) In response to Dr. Bentzen et al. (Letter). Int J Radiat Oncol Biol Phys 46(3):681–685CrossRef
40.
Zurück zum Zitat Roos DE (2000) Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol 56(3):315–322PubMedCrossRef Roos DE (2000) Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol 56(3):315–322PubMedCrossRef
41.
Zurück zum Zitat Roos DE, Fisher RJ (2003) Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) 15(6):342–344 Roos DE, Fisher RJ (2003) Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) 15(6):342–344
42.
Zurück zum Zitat Shakespeare TP, Lu JJ, Back MF et al (2003) Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol 21(11):2156–2162PubMedCrossRef Shakespeare TP, Lu JJ, Back MF et al (2003) Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol 21(11):2156–2162PubMedCrossRef
43.
Zurück zum Zitat Slotman BJ, van der Wal G, Kregar S, Langesdijk HA, Willems DL (2004) Patients’ appreciation of single fraction radiotherapy for painful bone metastases. (Letter). Palliat Med 18(1):72–73PubMedCrossRef Slotman BJ, van der Wal G, Kregar S, Langesdijk HA, Willems DL (2004) Patients’ appreciation of single fraction radiotherapy for painful bone metastases. (Letter). Palliat Med 18(1):72–73PubMedCrossRef
44.
Zurück zum Zitat Steenland E, Leer J, van Houwelingen H et al (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52(2):101–109PubMedCrossRef Steenland E, Leer J, van Houwelingen H et al (1999) The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52(2):101–109PubMedCrossRef
45.
Zurück zum Zitat Stevens G (2000) Fractionation schedules and radiation therapy waiting lists. Australas Radiol 44(4):365–366PubMedCrossRef Stevens G (2000) Fractionation schedules and radiation therapy waiting lists. Australas Radiol 44(4):365–366PubMedCrossRef
46.
Zurück zum Zitat Stevens G, Firth I (1995) Patterns of fractionation for palliation of bone metastases. Australas Radiol 39(1):31–35PubMed Stevens G, Firth I (1995) Patterns of fractionation for palliation of bone metastases. Australas Radiol 39(1):31–35PubMed
47.
Zurück zum Zitat Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352 Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD (2003) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15(6):345–352
48.
Zurück zum Zitat Szumacher E, Llewellyn-Thomas H, Franssen E et al (2005) Treatment of bone metastases with palliative radiotherapy: patients’ treatment preferences. Int J Radiat Oncol Biol Phys 61(5):1473–1481PubMedCrossRef Szumacher E, Llewellyn-Thomas H, Franssen E et al (2005) Treatment of bone metastases with palliative radiotherapy: patients’ treatment preferences. Int J Radiat Oncol Biol Phys 61(5):1473–1481PubMedCrossRef
49.
Zurück zum Zitat van den Hout WB, van der Linden YM, Steenland E et al (2003) Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 95(3):222–229PubMed van den Hout WB, van der Linden YM, Steenland E et al (2003) Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 95(3):222–229PubMed
50.
Zurück zum Zitat van der Linden YM, Leer JWH (2000) Impact of randomized trial-outcome in the treatment of painful bone metastases; patterns of practice among radiation oncologists. A matter of believers vs. non-believers? Radiother Oncol 56(3):279–281PubMedCrossRef van der Linden YM, Leer JWH (2000) Impact of randomized trial-outcome in the treatment of painful bone metastases; patterns of practice among radiation oncologists. A matter of believers vs. non-believers? Radiother Oncol 56(3):279–281PubMedCrossRef
51.
Zurück zum Zitat Williams MV, James ND, Summers ET, Barrett A, Ash DV (2006) National survey of radiotherapy fractionation practice in 2003. Clin Oncol (R Coll Radiol) 18(1):3–14 Williams MV, James ND, Summers ET, Barrett A, Ash DV (2006) National survey of radiotherapy fractionation practice in 2003. Clin Oncol (R Coll Radiol) 18(1):3–14
52.
Zurück zum Zitat Wu JS, Wong R, Johnston M, Bezjak A, Whelan T (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55(3):594–605PubMedCrossRef Wu JS, Wong R, Johnston M, Bezjak A, Whelan T (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55(3):594–605PubMedCrossRef
53.
Zurück zum Zitat Wu JS, Wong RK, Lloyd NS et al (2004) Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases—an evidence-based practice guideline. BMC Cancer 4:71PubMedCrossRef Wu JS, Wong RK, Lloyd NS et al (2004) Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases—an evidence-based practice guideline. BMC Cancer 4:71PubMedCrossRef
Metadaten
Titel
Review of patterns of practice and patients’ preferences in the treatment of bone metastases with palliative radiotherapy
verfasst von
Nicole M. E. Bradley
Janice Husted
Michael Sai Lai Sey
Amna F. Husain
Emily Sinclair
Kristin Harris
Edward Chow
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0161-3

Weitere Artikel der Ausgabe 4/2007

Supportive Care in Cancer 4/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.